Teva Pharmaceutical Industries (TEVA) Non-cash Items (2010 - 2018)

Teva Pharmaceutical Industries has disclosed Non-cash Items across 9 years of filings, most recently posting $24.1 million for Q4 2018.

• Quarterly Non-cash Items rose 225.49% year-over-year to $24.1 million in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $24.1 million (up 225.49% YoY) and the FY2018 annual result came in at $24.1 million, up 225.49% from the prior year.
• Non-cash Items rose to $24.1 million in Q4 2018, from $7.4 million in the prior quarter.
• Over five years, Non-cash Items peaked at $24.1 million in Q4 2018 and troughed at $7.4 million in Q4 2017.
• A 5-year average of $14.0 million and a median of $12.6 million in 2014 frame the typical range for Non-cash Items.
• Annual changes were most pronounced in 2017 — Non-cash Items sank 48.85% — and 2018, when it jumped 225.49%.
• Tracing TEVA's Non-cash Items over 5 years: stood at $12.6 million in 2014, then slipped by 10.55% to $11.3 million in 2015, then gained by 28.05% to $14.5 million in 2016, then sank by 48.85% to $7.4 million in 2017, then soared by 225.49% to $24.1 million in 2018.
• Business Quant data shows TEVA's Non-cash Items at $24.1 million in Q4 2018, $7.4 million in Q4 2017, and $14.5 million in Q4 2016.